Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naomi Kruhlak

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
International Journal of Toxicology|May 17, 2015
(Q)SAR: A Tool for the ToxicologistThomas Steinbach, Samantha Gad-McDonald, Naomi Kruhlak, et al.
Journal of the American Association for Laboratory Animal Science : JAALAS|April 4, 2015
Improving prediction of carcinogenicity to reduce, refine, and replace the use of experimental animalsTodd Bourcier, Tim McGovern, Lidiya Stavitskaya, et al.
Therapeutic Innovation & Regulatory Science|March 24, 2018
Translating New Science Into the Drug Review Process: The US FDA's Division of Applied Regulatory ScienceRodney Rouse, Naomi Kruhlak, James Weaver, et al.
Regulatory Toxicology and Pharmacology : RTP|October 15, 2020
Management of pharmaceutical ICH M7 (Q)SAR predictions - The impact of model updatesCatrin Hasselgren, Joel Bercu, Alex Cayley, et al.
Regulatory Toxicology and Pharmacology : RTP|August 7, 2015
Establishing best practise in the application of expert review of mutagenicity under ICH M7Chris Barber, Alexander Amberg, Laura Custer, et al.
Journal of Pharmacokinetics and Pharmacodynamics|October 8, 2014
Modeling and simulation for medical product development and evaluation: highlights from the FDA-C-Path-ISOP 2013 workshopKlaus Romero, Vikram Sinha, Sandra Allerheiligen, et al.
Regulatory Toxicology and Pharmacology : RTP|February 17, 2016
Extending (Q)SARs to incorporate proprietary knowledge for regulatory purposes: A case study using aromatic amine mutagenicityErnst Ahlberg, Alexander Amberg, Lisa D Beilke, et al.
Regulatory Toxicology and Pharmacology : RTP|February 16, 2016
Principles and procedures for implementation of ICH M7 recommended (Q)SAR analysesAlexander Amberg, Lisa Beilke, Joel Bercu, et al.
Regulatory Toxicology and Pharmacology : RTP|December 19, 2018
Principles and procedures for handling out-of-domain and indeterminate results as part of ICH M7 recommended (Q)SAR analysesAlexander Amberg, Roxanne V Andaya, Lennart T Anger, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
International Journal of Toxicology|May 17, 2015
(Q)SAR: A Tool for the ToxicologistThomas Steinbach, Samantha Gad-McDonald, Naomi Kruhlak, et al.
Journal of the American Association for Laboratory Animal Science : JAALAS|April 4, 2015
Improving prediction of carcinogenicity to reduce, refine, and replace the use of experimental animalsTodd Bourcier, Tim McGovern, Lidiya Stavitskaya, et al.
Therapeutic Innovation & Regulatory Science|March 24, 2018
Translating New Science Into the Drug Review Process: The US FDA's Division of Applied Regulatory ScienceRodney Rouse, Naomi Kruhlak, James Weaver, et al.
Regulatory Toxicology and Pharmacology : RTP|October 15, 2020
Management of pharmaceutical ICH M7 (Q)SAR predictions - The impact of model updatesCatrin Hasselgren, Joel Bercu, Alex Cayley, et al.
Regulatory Toxicology and Pharmacology : RTP|August 7, 2015
Establishing best practise in the application of expert review of mutagenicity under ICH M7Chris Barber, Alexander Amberg, Laura Custer, et al.
Journal of Pharmacokinetics and Pharmacodynamics|October 8, 2014
Modeling and simulation for medical product development and evaluation: highlights from the FDA-C-Path-ISOP 2013 workshopKlaus Romero, Vikram Sinha, Sandra Allerheiligen, et al.
Regulatory Toxicology and Pharmacology : RTP|February 17, 2016
Extending (Q)SARs to incorporate proprietary knowledge for regulatory purposes: A case study using aromatic amine mutagenicityErnst Ahlberg, Alexander Amberg, Lisa D Beilke, et al.
Regulatory Toxicology and Pharmacology : RTP|February 16, 2016
Principles and procedures for implementation of ICH M7 recommended (Q)SAR analysesAlexander Amberg, Lisa Beilke, Joel Bercu, et al.
Regulatory Toxicology and Pharmacology : RTP|December 19, 2018
Principles and procedures for handling out-of-domain and indeterminate results as part of ICH M7 recommended (Q)SAR analysesAlexander Amberg, Roxanne V Andaya, Lennart T Anger, et al.
Pageof 1